BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38158602)

  • 1. A Massive Venlafaxine Intoxication: Evolution of Cardiac Toxicity with Venlafaxine and O-Desmethylvenlafaxine Elimination Kinetics: A Grand Round.
    Couderc S; Gabriel A; Decheiver S; N'Zoué Kanga S; Fikanni A; Flint H; Pihan F; Sahar A; Tifrea M; Tifrea A; Marsaud JP; Vandroux D
    Ther Drug Monit; 2024 Apr; 46(2):133-137. PubMed ID: 38158602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism.
    Castanares-Zapatero D; Gillard N; Capron A; Haufroid V; Hantson P
    Forensic Sci Int; 2016 Sep; 266():e48-e51. PubMed ID: 27328779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of venlafaxine dosage, valproic acid concentration, sex, and age on steady state dose-corrected concentrations of venlafaxine and O-desmethylvenlafaxine: A retrospective analysis of therapeutic drug monitoring data in a Chinese population.
    Wang ZZ; Deng SH; Lu HY; Li L; Zhu XQ; Hu JQ; Xie HS; Chen HZ; Chen YQ; Zhang M; Fang ZY; Wen YG; Shang DW
    Hum Psychopharmacol; 2020 May; 35(3):e2733. PubMed ID: 32239743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.
    Vinetti M; Haufroid V; Capron A; Classen JF; Marchandise S; Hantson P
    Clin Toxicol (Phila); 2011 Nov; 49(9):865-9. PubMed ID: 22077251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
    Murrell MD; Cruz DA; Javors MA; Thompson PM
    J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.
    Ilett KF; Kristensen JH; Hackett LP; Paech M; Kohan R; Rampono J
    Br J Clin Pharmacol; 2002 Jan; 53(1):17-22. PubMed ID: 11849190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450-mediated inhibition of venlafaxine metabolism by trimipramine.
    Kowalewski C; Haen E; Hiemke C; Ridders F; Endres K; Gründer G; Paulzen M; Schoretsanitis G
    Int Clin Psychopharmacol; 2019 Sep; 34(5):241-246. PubMed ID: 31094902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of clinical response to venlafaxine: relevance of plasma level and chirality.
    Gex-Fabry M; Balant-Gorgia AE; Balant LP; Rudaz S; Veuthey JL; Bertschy G
    Eur J Clin Pharmacol; 2004 Feb; 59(12):883-91. PubMed ID: 14704834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid determination of venlafaxine and O-desmethylvenlafaxine in human plasma by high-performance liquid chromatography with fluorimetric detection.
    Vu RL; Helmeste D; Albers L; Reist C
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):195-201. PubMed ID: 9448076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of antidepressant response to venlafaxine by a combination of early response assessment and therapeutic drug monitoring.
    Stamm TJ; Becker D; Sondergeld LM; Wiethoff K; Hiemke C; O'Malley G; Ricken R; Bauer M; Adli M
    Pharmacopsychiatry; 2014 Jul; 47(4-5):174-9. PubMed ID: 25054625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals.
    Howell SR; Hicks DR; Scatina JA; Sisenwine SF
    Xenobiotica; 1994 Apr; 24(4):315-27. PubMed ID: 8059535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk.
    Ilett KF; Hackett LP; Dusci LJ; Roberts MJ; Kristensen JH; Paech M; Groves A; Yapp P
    Br J Clin Pharmacol; 1998 May; 45(5):459-62. PubMed ID: 9643618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect Of Chinese Herb Danzhi Xiaoyao Pills On Pharmacokinetics Of Venlafaxine In Beagles.
    Zhu YL; Li SL; Chen KL; Ma KP; Wu DQ; Qiu XJ
    Drug Des Devel Ther; 2019; 13():3343-3355. PubMed ID: 31571835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
    Pandey A; Price A; Ayala-Lopez N; Garza KY; Marzinke MA; Knezevic CE
    J Pharm Biomed Anal; 2024 Jun; 243():116082. PubMed ID: 38461636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression.
    Komahashi-Sasaki H; Yasui-Furukori N; Sasaki T; Shinozaki M; Hayashi Y; Kato K; Inoue Y; Tsuchimine S; Watanabe T; Sugawara N; Shimoda K
    Ther Drug Monit; 2021 Oct; 43(5):681-687. PubMed ID: 33306568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of venlafaxine and O-desmethylvenlafaxine in human serum using HPLC analysis.
    Waschgler R; Moll W; König P; Conca A
    Int J Clin Pharmacol Ther; 2004 Dec; 42(12):724-8. PubMed ID: 15624289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of venlafaxine extended release 75  mg and desvenlafaxine 50  mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.
    Nichols AI; Focht K; Jiang Q; Preskorn SH; Kane CP
    Clin Drug Investig; 2011; 31(3):155-67. PubMed ID: 21288052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O-Desmethylvenlafaxine Concentrations in a Large Patient Cohort.
    Kringen MK; Bråten LS; Haslemo T; Molden E
    J Clin Psychopharmacol; 2020; 40(2):137-144. PubMed ID: 32134850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic drug monitoring of antidepressants: Why venlafaxine is the most monitored drug? A review of literature].
    Couderc S; Mory C; Darnaud L; Saint-Marcoux F
    Therapie; 2021; 76(6):725-733. PubMed ID: 33551091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of renal disease on the disposition of venlafaxine.
    Troy SM; Schultz RW; Parker VD; Chiang ST; Blum RA
    Clin Pharmacol Ther; 1994 Jul; 56(1):14-21. PubMed ID: 8033490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.